[DOC] Levodopa induced dyskinesia (LID) occurs in about 80% of patients ...,https://n.neurology.org/highwire/filestream/130031/field_highwire_adjunct_files/4/E5.doc
[DOC] Treatment of Parkinson's Disease with Motor Fluctuations and ...,https://n.neurology.org/highwire/filestream/129745/field_highwire_adjunct_files/1/TablesE1--E2.doc
[DOC] Response to Reviewers PLOS ONE manuscript ID#: PONE-D-20 ...,https://journals.plos.org/plosone/article/file%3Fid%3D10.1371/journal.pone.0237472.s001%26type%3Dsupplementary
[DOC] Medical Management of Parkinson's Disease - Movement Disorder ...,https://www.movementdisorders.org/MDS-Files1/MDS-ES/Birmingham-Course-Materials/17BhatiaParoxysmalMovementDisorders.doc
"[DOC] Prevention, Identification, and Management of Tardive Dyskinesia",https://www.ttuhsc.edu/medicine/psychiatry/documents/prevention_identification_and_management_of_tardive_dyskinesia.doc
[DOC] Olanzapine for the Treatment of Tardive Dyskinesia in ...,http://links.lww.com/JCP/A50
[DOC] Dyskinesia Template and Instructions- Final_1.doc,https://www.michaeljfox.org/files/accelerate/Dyskinesia%2520Template%2520and%2520Instructions-%2520Final_1.doc
[DOC] Genetics of Primary ciliary dyskinesia - HAL-Inserm,http://www.hal.inserm.fr/docs/00/40/65/04/DOC/PCD_Review_Escudier.doc
[DOC] Supplementary table - IOS Press,https://content.iospress.com/download/journal-of-huntingtons-disease/jhd140120%3Fid%3Djournal-of-huntingtons-disease/jhd140120%26supplementaryFilename%3Djhd-4-2-jhd140120-s001.doc
[DOC] Manuscript TD.doc,https://jemds.com/data_pdf/Manuscript%2520TD.doc
[DOC] Supplementary material - Biological Psychiatry,https://www.biologicalpsychiatryjournal.com/cms/10.1016/j.biopsych.2006.11.032/attachment/0c11590a-581e-46f1-80cc-4ce8d940d2fe/mmc1.doc
[DOC] Psychosis and Pharmacology of Anti-psychotic Agents - CECentral,https://www.cecentral.com/index.php%3Ftpl%3Dcounter%26counter%3Dtrue%26type%3Dpdf%26aid%3D22757%26url%3Dhttps%253A%252F%252Fwww.cecentral.com%252Fassets%252F22757%252FUnit4_Pharmacology_of_Antipsychotics.doc
[DOC] Consent for Medication Template (Care207) - Placer County,https://www.placer.ca.gov/DocumentCenter/View/40351/Care-207-DOC
"[DOC] Helpful information for Blue Badge services (England) (Word, 224KB)",https://www.parkinsons.org.uk/sites/default/files/2018-10/Information%2520for%2520blue%2520badge%2520assessors_england.doc
[DOC] Supplementarytable2.doc - Research Square,https://assets.researchsquare.com/files/rs-43715/v1/Supplementarytable2.doc
[DOC] Schema di Richiesta da presentare alla Segreteria ... - AUSL RE,https://www.ausl.re.it/allegati/tetrabenazina%2520mod%2520unico%2520%2520rich.%2520ins.%2520ctp.doc
[DOC] Wiliam Sepulvado - medQuest LTD,https://www.medquestltd.com/mq/wp-content/uploads/2014/05/Reglan-sample.doc
[DOC] Primary ciliary dyskinesia: first health-related quality of life measures ...,https://eprints.soton.ac.uk/399375/1/__filestore.soton.ac.uk_users_jlucas1_mydocuments_Documents_Publications%252520in%252520preparation_respiratory%252520writeups_QOLPCD%252520child%252520deve_QOL-PCD%252520pediatric%252520R2%252520CLEAN.doc
[DOC] Orap (Pimozide) - Neurology Center of Wichita,http://www.pedsbrain.com/docs/ncw-links/ncw-drug/med%2520sheet-ORAP.doc
[DOC] Patient Rytary Dosing Sheet from Carbidopa/Levodopa,http://parkinsonsassociation.org/wp-content/uploads/2016/03/RytaryForConversion.doc
[DOC] Ciliary function and the treatment of primary ciliary dyskinesia ...,https://www.cipp-meeting.org/CIPPIX/proceedings2009/others/cdmaterial/4I%26I10ChristopherOCallaghan.doc
[DOC] 8- Psychotropic drug use care plan.doc - LeadingAge,https://leadingage.org/sites/default/files/8-%2520Psychotropic%2520drug%2520use%2520care%2520plan.doc
[DOC] “DMSH Pharmacological Practice Guidelines for the Treatment of ...,https://njms.rutgers.edu/departments/psychiatry/documents/Dr.ELDOFlyerJan182012.doc
[DOC] CHECKLIST - Minnesota.gov,https://mn.gov/doc/assets/App._-_Checklist_-_Mental_Health_5-05_tcm1089-275922.doc
[DOC] AusPAR Attachment: Product Information: Safinamide - Therapeutic ...,https://www.tga.gov.au/sites/default/files/auspar-safinamide-190327-pi.doc
[DOC] Safinamide (Xadago®) – Information Sheet for Primary Care,https://ipswichandeastsuffolkccg.nhs.uk/Portals/1/Content/Members%2520Area/Clinical%2520Area/Medicine%2520managment/Medical%2520conditions/Safinamide%2520-%2520factsheet%2520final%2520approved.doc
[DOC] Meriwether Ventures - Zumbro House,http://www.zumbrohouse.com/images/DISCUS.doc
[DOC] COMMON SIDE EFFECTS OF PSYCHOTROPICS - Quia,https://www.quia.com/files/quia/users/tammybrock/COMMON-SIDE-EFFECTS-OF-PSYCHOTROPICS.doc
[DOC] Table 4,https://www.jns-journal.com/cms/10.1016/j.jns.2012.10.024/attachment/c87af076-1c18-4648-bce6-e7a073cead49/mmc3.doc
[DOC] FRESNO COUNTY MENTAL HEALTH INFORMED MEDICATION ...,https://www.co.fresno.ca.us/home/showpublisheddocument/18183/636438474509900000
[DOC] mmc1.doc,https://www.resmedjournal.com/cms/10.1016/j.rmed.2017.02.001/attachment/63ea423a-7e6a-45ea-93f3-88f87704e6d5/mmc1.doc
[DOC] ijrpm-6-111-supplementary.doc,https://www.clinmedjournals.org/articles/ijrpm/ijrpm-6-111-supplementary.doc
[DOC] Division of Medical Genetics Geneva University School of Medicine ...,http://www.medgen.unige.ch/kartagener/PCD-WEB-publications%25202002.doc
[DOC] 610454002_1576_nosp.doc,https://www.rad-ar.or.jp/siori/kusuri_sp_e/610454002_1576_nosp.doc
[DOC] Use of electron tomography in the diagnosis of PCD - Discovery ...,https://discovery.dundee.ac.uk/files/18440372/Use_of_electron_tomography_in_the_diagnosis_of_PCD_ultrastructural_pathology_with_review_changes.doc
[DOC] Methotrexate - Joint Walsall Formulary,http://www.walsallformulary.nhs.uk/docs/launcher.asp%3FdocID%3D137
[DOC] INTERVIEW OF MARILYN FOSS - Maine.gov,https://www.maine.gov/dhhs/sites/maine.gov.dhhs/files/documents/riverview/FossFinal.doc
"[DOC] Tablets containing 75 mg, 150 mg or 225 mg venlafaxine (as ...",https://www.ethypharm.co.uk/wp-content/uploads/sites/3/2020/12/Pipexus-PI-August-2020.doc
[DOC] First generation (typical) antipsychotic depots in adults - GMMMG,https://gmmmg.nhs.uk/scps/first-generation-typical-antipsychotic-depots-in-adults/gmmmg-scp-typical-antipsychotic-depot-injections-gmmmg-approved-19-5-16-v1-2/
[DOC] Clinical Psychotropic Progress Note,https://www.flrules.org/gateway/readRefFile.asp%3FrefId%3D5365%26filename%3D63N-1%2520Form%2520HS%2520006%2520Final%2520Revised.doc
